🔴 Indaptus Therapeutics is trading 6.25% down today with no clear company-specific catalyst

Indaptus Therapeutics is trading 6.25% down at $3.75, with no clear company-specific catalyst identified for September 25, 2026.

• The previously announced $24.0 million private placement involved 20,338,974 shares and dates to September 8; it is not a new announcement today.
• Broader markets are modestly higher, so the decline does not clearly track overall market direction.
• Continued volatility and financing-related supply concerns may be contributing, but that explanation remains unconfirmed.